Tags: Drug.
Pembrolizumab (formerly lambrolizumab;also known as MK-3475) is a drug in development by Merck that targets the programmed cell death 1 (PD-1) receptor. The drug is intended for use in treating metastatic melanoma.
Loading...
This page contains content from the copyrighted Wikipedia article "Pembrolizumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.